Skip to content

Celator Pharmaceuticals Inc

Delisted

CIK 1327467fmd_1ZA4CV1VJ1XKD5JQW2GKBQX2ERManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2000 to Mar 31, 2016, 29 periods

Latest annual · FY2015

Millions
Operating income
(18)
Net income
(19)
Free cash flow
(16)

Latest quarter · Q1 FY2016

Millions
Operating income
(5)
Net income
(6)
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2010 to FY2015
n/m

Celator Pharmaceuticals Inc financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Operating income-$18.2 million-$17.9 million10-K 2016-03-21 · proof
Net income-$19.3 million-$16.9 million10-K 2016-03-21 · proof
Cash from operating activities-$15.5 million-$14.4 million10-K 2016-03-21 · proof
Free cash flow-$15.5 million-$14.5 million10-K 2016-03-21 · proof
Total assets$25.2 million$35.1 million-28.2%10-Q 2016-05-10 · proof
Total liabilities$18.7 million$13.2 million+41.4%10-Q 2016-05-10 · proof
Cash and cash equivalents$23.3 million$32.4 million-28.3%10-K 2016-03-21 · proof
Total debt$14.5 million$10.1 million+42.9%10-Q 2016-05-10 · proof
What was Celator Pharmaceuticals Inc's operating income in fiscal 2015?
Celator Pharmaceuticals Inc reported operating income of -$18.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$17.9 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2016. SEC
What was Celator Pharmaceuticals Inc's net income in fiscal 2015?
Celator Pharmaceuticals Inc reported net income of -$19.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$16.9 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2016. SEC
What was Celator Pharmaceuticals Inc's cash from operating activities in fiscal 2015?
Celator Pharmaceuticals Inc reported cash from operating activities of -$15.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$14.4 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2016. SEC
What was Celator Pharmaceuticals Inc's free cash flow in fiscal 2015?
Celator Pharmaceuticals Inc reported free cash flow of -$15.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$14.5 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2016. SEC
What are Celator Pharmaceuticals Inc's total assets?
As of Dec 31, 2015, Celator Pharmaceuticals Inc reported total assets of $25.2 million, against $35.1 million a year earlier (-28.2%). Source: the 10-Q filed with the SEC on May 10, 2016 (restated). SEC
What are Celator Pharmaceuticals Inc's total liabilities?
As of Dec 31, 2015, Celator Pharmaceuticals Inc reported total liabilities of $18.7 million, against $13.2 million a year earlier (+41.4%). Source: the 10-Q filed with the SEC on May 10, 2016 (restated). SEC
What are Celator Pharmaceuticals Inc's cash and cash equivalents?
As of Dec 31, 2015, Celator Pharmaceuticals Inc reported cash and cash equivalents of $23.3 million, against $32.4 million a year earlier (-28.3%). Source: the 10-K filed with the SEC on Mar 21, 2016. SEC
What is Celator Pharmaceuticals Inc's total debt?
As of Dec 31, 2015, Celator Pharmaceuticals Inc reported total debt of $14.5 million, against $10.1 million a year earlier (+42.9%). Source: the 10-Q filed with the SEC on May 10, 2016 (restated). SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1327467&period_type=annual&limit=5"

Information only, not investment advice.